Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jundan Xie

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Hematology (Amsterdam, Netherlands)|May 11, 2022
Clinical and molecular characteristics of acute myeloid leukemia with MPL mutationYu Chen, Jundan Xie, Zhen Shen, et al.
Annals of Hematology|October 23, 2025
A novel fusion gene of NUP98::CYP2F2P in myeloid neoplasmWusixian Huang, Fenghong Zhang, Jundan Xie, et al.
Cancer Genetics|July 8, 2014
High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemiaJundan Xie, Qian Wang, Qinrong Wang, et al.
International Journal of Hematology|June 5, 2015
Prognostic impact of residual normal metaphases in acute myeloid leukemia with t(8;21)(q22;q22)Lijun Wen, Jing Xia, Qinrong Wang, et al.
Molecular Carcinogenesis|November 2, 2022
Blast phase of chronic myeloid leukemia with concurrent BCR::ABL1 and SET::NUP214: A report of two casesYan Chen, Qian Wang, Jiannong Cen, et al.
Frontiers in Oncology|December 15, 2023
Identification of a venetoclax-resistance prognostic signature base on 6-senescence genes and its clinical significance for acute myeloid leukemiaPeng Ke, Jundan Xie, Ting Xu, et al.
Frontiers in Oncology|September 13, 2021
Case Report: The Formation of a Truncated PAX5 Transcript in a Case of Ph-Positive Mixed Phenotype Acute Leukemia With dic(7;9)(p11-p13;p13)Yan Yu, Zhao Zeng, Jundan Xie, et al.
Clinical Case Reports|January 27, 2023
Insights from a rare myeloproliferative neoplasm with coexisting <i>BCR-ABL1</i> fusion gene, <i>CALR,</i> and <i>TET2</i> mutations treated with nilotinib and ruxolitinibLi Huo, Jundan Xie, Qian Wang, et al.
Molecular Cancer|April 17, 2015
Transcriptome sequencing reveals CHD1 as a novel fusion partner of RUNX1 in acute myeloid leukemia with t(5;21)(q21;q22)Hong Yao, Jinlan Pan, Chunxiao Wu, et al.
Journal of Biomedical Nanotechnology|November 12, 2015
Modulating the Growth and Imatinib Sensitivity of Chronic Myeloid Leukemia Stem/Progenitor Cells with Pullulan/MicroRNA Nanoparticles In VitroWenjuan Ma, Jian Liu, Jundan Xie, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Hematology (Amsterdam, Netherlands)|May 11, 2022
Clinical and molecular characteristics of acute myeloid leukemia with MPL mutationYu Chen, Jundan Xie, Zhen Shen, et al.
Annals of Hematology|October 23, 2025
A novel fusion gene of NUP98::CYP2F2P in myeloid neoplasmWusixian Huang, Fenghong Zhang, Jundan Xie, et al.
Cancer Genetics|July 8, 2014
High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemiaJundan Xie, Qian Wang, Qinrong Wang, et al.
International Journal of Hematology|June 5, 2015
Prognostic impact of residual normal metaphases in acute myeloid leukemia with t(8;21)(q22;q22)Lijun Wen, Jing Xia, Qinrong Wang, et al.
Molecular Carcinogenesis|November 2, 2022
Blast phase of chronic myeloid leukemia with concurrent BCR::ABL1 and SET::NUP214: A report of two casesYan Chen, Qian Wang, Jiannong Cen, et al.
Frontiers in Oncology|December 15, 2023
Identification of a venetoclax-resistance prognostic signature base on 6-senescence genes and its clinical significance for acute myeloid leukemiaPeng Ke, Jundan Xie, Ting Xu, et al.
Frontiers in Oncology|September 13, 2021
Case Report: The Formation of a Truncated PAX5 Transcript in a Case of Ph-Positive Mixed Phenotype Acute Leukemia With dic(7;9)(p11-p13;p13)Yan Yu, Zhao Zeng, Jundan Xie, et al.
Clinical Case Reports|January 27, 2023
Insights from a rare myeloproliferative neoplasm with coexisting <i>BCR-ABL1</i> fusion gene, <i>CALR,</i> and <i>TET2</i> mutations treated with nilotinib and ruxolitinibLi Huo, Jundan Xie, Qian Wang, et al.
Molecular Cancer|April 17, 2015
Transcriptome sequencing reveals CHD1 as a novel fusion partner of RUNX1 in acute myeloid leukemia with t(5;21)(q21;q22)Hong Yao, Jinlan Pan, Chunxiao Wu, et al.
Journal of Biomedical Nanotechnology|November 12, 2015
Modulating the Growth and Imatinib Sensitivity of Chronic Myeloid Leukemia Stem/Progenitor Cells with Pullulan/MicroRNA Nanoparticles In VitroWenjuan Ma, Jian Liu, Jundan Xie, et al.
Pageof 2